A Study to Investigate the Plasma Concentration of YM150 After Repeated Administration to Elderly Subjects

NCT01514825 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Elderly Subject
Pharmacokinetic of YM150

Interventions

DRUG: YM150
DRUG: Placebo

Sponsor

Astellas Pharma Inc